OTCMKTS:ISCO International Stem Cell (ISCO) Stock Price, News & Analysis $0.16 -0.01 (-7.46%) As of 11/13/2026 09:38 AM Eastern Add Compare Share Share Stock Analysis Stock AnalysisChartEarningsSEC Filings About International Stem Cell Stock (OTCMKTS:ISCO) View Price History Chart DataSkip Price History Chart 1 Day 5 Days 30 Days 90 Days 1 Year Advanced 1 Day 1 Day 5 Days 30 Days 90 Days 1 Year Advanced Show volume Show extended hours Get ISCO alerts:Sign Up Key Stats Today's Range$0.16▼$0.1650-Day Range$0.14▼$0.4252-Week Range$0.12▼$0.54Volume28,563 shsAverage Volume32,350 shsMarket Capitalization$1.27 millionP/E RatioN/ADividend YieldN/APrice TargetN/AConsensus RatingN/A Company Overview International Stem Cell Corporation (OTCMKTS:ISCO) is a biotechnology company focused on developing regenerative medicine products based on human parthenogenetic stem cells. These cells are derived from unfertilized human oocytes and are intended to provide an alternative source of pluripotent stem cells without using fertilized embryos. The company has researched potential applications for its stem-cell technology in areas including ophthalmology, neurological disorders and tissue regeneration. Its development programs have included stem-cell-derived retinal pigment epithelial cells for eye diseases and other preclinical therapeutic applications. The company has also been associated with Lifeline Skin Care, a business offering skincare products formulated with human stem-cell-derived growth factors and related biotechnology ingredients. International Stem Cell Corporation was established in the United States and has historically conducted research and commercial activities through subsidiaries and partners. Public information about the company’s current operations, leadership and geographic reach is limited, and its development programs and business activities may have changed over time.AI Generated. May Contain Errors. Read More International Stem Cell Stock Analysis - MarketRank™See Top-Rated MarketRank™ Stocks3rd Percentile Overall ScoreISCO MarketRank™: 0.147347740665 of 5 starsInternational Stem Cell scored higher than 3% of companies evaluated by MarketBeat. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation. Analyst's OpinionN/AAnalyst RatingN/A Consensus RatingThere is not enough analysis data for International Stem Cell. Earnings and Valuation0.0 / 5Proj. Earnings GrowthN/A Price to Earnings Ratio vs. the MarketThe P/E ratio of International Stem Cell is -1.94, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Earnings Ratio vs. SectorThe P/E ratio of International Stem Cell is -1.94, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings. Short Interest3.0 / 5Short Interest LevelHealthy Percentage of Shares Shorted0.00% of the float of International Stem Cell has been sold short.Short Interest Ratio / Days to CoverInternational Stem Cell has a short interest ratio ("days to cover") of 0, which is generally considered an acceptable ratio of short interest to trading volume.Change versus previous month Dividend0.0 / 5Dividend StrengthN/A Dividend YieldInternational Stem Cell does not currently pay a dividend.Dividend GrowthInternational Stem Cell does not have a long track record of dividend growth. News and Social Media0.6 / 5News SentimentN/A Search Interest3 people have searched for ISCO on MarketBeat in the last 30 days. Company Ownership0.7 / 5Insider TradingN/A Insider Buying vs. Insider SellingIn the past three months, International Stem Cell insiders have not sold or bought any company stock.Percentage Held by Insiders78.05% of the stock of International Stem Cell is held by insiders. A high percentage of insider ownership can be a sign of company health.Percentage Held by InstitutionsInternational Stem Cell has minimal institutional ownership at this time.Read more about International Stem Cell's insider trading history. Receive ISCO Stock News and Ratings via Email Sign-up to receive the latest news and ratings for International Stem Cell and its competitors with MarketBeat's FREE daily newsletter. Submit View SMS TermsSMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. ISCO Stock News HeadlinesInternational Stem Cell (ISCO) Hisse Fiyatı Bugün Ne Kadar?October 13, 2026 | tr.investing.comISCO - International Stem Cell CorporationSeptember 18, 2026 | seekingalpha.comWhy I'm selling my Snapback Indicator for just $7For Black Friday, Base Camp Trading's Thomas Wood is offering lifetime access to his proprietary Snapback Indicator for a single $7 payment. Others previously paid $500. The indicator flashes a Crash Alert as a cue to exit or go short, and a Bull Run Alert as a cue to buy or go long. No strings attached, and Wood says there is an unusual reason behind the steep discount.November 15 at 1:00 AM | Base Camp Trading (Ad)Der aktuelle Kurs der International Stem Cell Corp Aktie beträgt 0,490.August 27, 2026 | de.investing.comما هو سعر سهم International Stem Cell (ISCO) اليوم؟August 22, 2026 | sa.investing.comSpaceflight accelerates the aging of human blood-forming stem cellsSeptember 9, 2025 | yahoo.comStem Cell Therapy Begins to Emerge as Potential IBD TreatmentJuly 15, 2025 | msn.comSee photos from final round of 2025 PGA Tour ISCO ChampionshipJuly 15, 2025 | msn.comSee More Headlines ISCO Stock Analysis - Frequently Asked Questions How have ISCO shares performed this year? International Stem Cell's stock was trading at $0.14 on January 1st, 2026. Since then, ISCO stock has increased by 10.7% and is now trading at $0.1550. How were International Stem Cell's earnings last quarter? International Stem Cell Corp. (OTCMKTS:ISCO) announced its quarterly earnings data on Thursday, August, 13th. The biotechnology company reported ($0.01) earnings per share for the quarter. The biotechnology company earned $2.67 million during the quarter. How do I buy shares of International Stem Cell? Shares of ISCO stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. What other stocks do shareholders of International Stem Cell own? Based on aggregate information from My MarketBeat watchlists, some other companies that International Stem Cell investors own include Canopy Growth (CGC), FuelCell Energy (FCEL), Boeing (BA), Salesforce (CRM), EOG Resources (EOG), GE Aerospace (GE) and Denison Mine (DNN). Company Calendar Last Earnings8/13/2026Today11/15/2026Fiscal Year End12/31/2026Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeOTCMKTS SectorHealthcare Industry Biotechnology Sub-IndustryBiotechnology Current SymbolOTCMKTS:ISCO CIK1355790 Webwww.internationalstemcell.com Phone(760) 940-6383Fax760-476-0600Employees33Year Founded2001Profitability EPS (Trailing Twelve Months)($0.08) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income-$420 thousand Net Margins-6.12% Pretax Margin-6.12% Return on EquityN/A Return on Assets-11.47% Debt Debt-to-Equity RatioN/A Current Ratio0.79 Quick Ratio0.45 Sales & Book Value Annual Sales$9.10 million Price / Sales0.14 Cash FlowN/A Price / Cash FlowN/A Book Value($0.51) per share Price / Book-0.30Miscellaneous Outstanding Shares8,163,000Free Float1,792,000Market Cap$1.27 million OptionableNot Optionable Beta0.08 Social Links 10 Best Stocks to Own in Fall 2026AI spending is reshaping the market, and the opportunity extends far beyond the biggest chipmakers. Discover 10 stocks set to benefit from powerful trends in AI infrastructure, cloud computing, energy, capital returns, and consumer growth this fall.Get This Free Report This page (OTCMKTS:ISCO) was last updated on 11/13/2026 by MarketBeat.com Staff. From Our PartnersWhy I'm selling my Snapback Indicator for just $7For Black Friday, Base Camp Trading's Thomas Wood is offering lifetime access to his proprietary Snapback Indi...Base Camp Trading | SponsoredToday's free pick (on me)Elon Musk doesn't own the chip inside every Tesla, Starlink dish, and AI satellite - he licenses it from one l...Behind the Markets | SponsoredDrop these 5 stocks before the market opens tomorrow!The Wall Street Journal called it the "$64 trillion question": is a stock market crash on the way? Weiss Ratin...Weiss Ratings | SponsoredYour free book is about to disappearBill Poulos is giving away his 'Safe Trade Options Formula' book for free - but only for a limited time throug...Profits Run | SponsoredThe investigation Porter spent tens of thousands to documentPorter Stansberry flew the Porter and Co. team 3,300 miles to Dublin to investigate a 17-year investing experi...Porter & Company | SponsoredURGENT: If you own a home, please review the map below.More than 1,300 red dots are scattered across the country, and 2,800 more are already on the way. Jim Rickards...Paradigm Press | SponsoredTrump’s EO to send this $5 stock ripping higher…?President Trump's December executive order declared space a national security and economic priority, fueling a...Traders Agency | SponsoredUranium Mine Flood That Sparked a 2006 Price Surge ReturnsIn 2006, a flooded mine at Cigar Lake sent uranium prices from the $50 range to $136 in eight months. This pa...Digest Publishing | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding International Stem Cell Corp. Please log in to your account or sign up in order to add this asset to your watchlist. Share International Stem Cell With A Colleague Link copied to clipboard. Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
